Amish Family Flees Ohio to Avoid Daughter's Leukemia Treatment

The family of a 10-year-old Amish girl has fled the state of Ohio in an effort to avoid having the girl subjected to anti-cancer treatments.

Andy and Anna Hershberger and their daughter Sarah have disappeared from their home in Homer Township, Ohio, presumably to avoid the treatments that the state of Ohio had deemed necessary to save the girl's life. Sarah has been diagnosed with a treatable type of leukemia, but after one round of chemotherapy at Akron Children's Hospital, the girl decided she could not endure it.

This is only the latest in a real-life drama being played out between modern medicine and the state of Ohio on one side, and the traditions of an Amish community on the other.

Family opts out of treatment

Officials at Akron Children's believe they have a moral and legal responsibility to see to it that the girl receives the treatments that evidence shows can save her life. They say she faces almost certain death without them.

Sarah's parents had initially agreed to the two-year treatment protocol, but before a second round of chemotherapy was to begin, Sarah appealed to her parents for it to end, claiming it was making her very ill.

After extensive prayer, they stopped bringing her to treatments. Akron Children's sought guardianship over the girl in an effort to make sure she received treatment. An Ohio appeals court granted it, saying the rights of the state to protect a child outweighed the religious beliefs of the child's parents in this case. The decision has been appealed to the Ohio Supreme Court.

In the meantime, the family has apparently fled their farm in Homer Township, and their whereabouts remain unknown. Word is that the girl is receiving treatment in the form of herbs and vitamins.

Feature photo depicts the Hershberger family farm. Photo credits: Medina Gazette/Kiera Manion-Fischer

Source: Medina Gazette

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap